Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Erythro-megakaryocytic transcription factors associated with hereditary anemia.

Blood - 15 May 2014

Crispino John D, Weiss Mitchell J

Abstract excerpt

Most heritable anemias are caused by mutations in genes encoding globins, red blood cell (RBC) membrane proteins, or enzymes in the glycolytic and hexose monophosphate shunt pathways. A less common class of genetic anemia is caused by mutations that alter the functions of erythroid transcription factors (TFs). Many TF mutations associated with heritable anemia cause truncations or amino acid substitutions,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anemia
Share to Erythroblasts
Share to GATA1 Transcription Factor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation

Share to Hematopoiesis

Share to Kruppel-Like Transcription Factors

Share to Megakaryocytes

Share to Quantitative Trait Loci

Source

Open in PubMed Open full text

Identifiers

PMID: 24652993
DOI: 10.1182/blood-2014-01-453167
PMCID: PMC4023417

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Erythro-megakaryocytic transcription factors associated with hereditary anemia.PMID 24652993Read ↗

Genetic Modifiers of Hemoglobin Expression from a Clinical Perspective in Hemoglobinopathy Patients with Beta Thalassemia and Sickle Cell DiseaseSemantic proximity Read ↗

Genetics and Genomics Approaches for Diagnosis and Research Into Hereditary AnemiasSemantic proximity Read ↗

Molecular basis of β thalassemia and potential therapeutic targets.Semantic proximity Read ↗

A Small Key for a Heavy Door: Genetic Therapies for the Treatment of HemoglobinopathiesSemantic proximity Read ↗

The molecular basis of α-thalassemia.Semantic proximity Read ↗

Single Nucleotide Polymorphisms in XMN1-HBG2, HBS1L-MYB, and BCL11A and Their Relation to High Fetal Hemoglobin Levels That Alleviate AnemiaSemantic proximity Read ↗

Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical ManagementSemantic proximity Read ↗

Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease.Semantic proximity Read ↗

Molecular genetics of β-thalassemiaSemantic proximity Read ↗

Genetic association studies in β-hemoglobinopathiesSemantic proximity Read ↗

Single-nucleotide-level mapping of DNA regulatory elements that control fetal hemoglobin expression.Semantic proximity Read ↗

Identifying genetic variants and pathways associated with extreme levels of fetal hemoglobin in Sickle Cell Disease in Tanzania.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.